Internal restructuring
Südösterreich; Steiermark; Graz
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

400 jobs
Number of planned job losses
Job loss
Announcement Date
17 November 2010
Employment effect (start)
1 April 2011
Foreseen end date
31 December 2013


On 17 November 2010, Swiss pharmaceutical company Roche announced plan to close its plant in the Styrian capital Graz, thus all 400 employees will lose their jobs by the end of 2013.

The closure of Graz plant is part of the company's worldwide restructuring programme 'Operational Excellence', whereby some 4,800 jobs will be made redundant overall (see case 16343). The development and production of diagnostics, which has been concentrated in the Graz plant, will be relocated to the Swiss town of Rotkreuz, where the headquarters of Roche's business line 'Professional Diagnostics' is located. Roche Diagnostics had been an important part of the Styrian human technology cluster. The first dismissals are scheduled to take place in the second quarter of 2011 at the earliest. By the end of 2013, the plant will be shut down.

The company's spokesperson in Graz showed surprise at the unexpected announcement and promised to try to find fair solutions for the affected workers which might include social plans. The regional Chamber of Labour harshly criticised the company's announcement, and plans to examine whether the pharmaceutical company will have to repay funds it has so far received.


  • 17 November 2010: Die Presse
  • 17 November 2010: Der Standard
  • 18 November 2010: Wirtschaftsblatt
  • 17 November 2010: Kleine Zeitung


Eurofound (2010), Roche, Internal restructuring in Austria, factsheet number 71208, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71208.